Standard BioTools Total Assets 2010-2025 | LAB
Standard BioTools total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
| Standard BioTools Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $612 |
| 2023 | $323 |
| 2022 | $390 |
| 2021 | $275 |
| 2020 | $325 |
| 2019 | $265 |
| 2018 | $304 |
| 2017 | $287 |
| 2016 | $306 |
| 2015 | $370 |
| 2014 | $408 |
| 2013 | $117 |
| 2012 | $114 |
| 2011 | $79 |
| 2010 | $25 |
| 2009 | $32 |
| Standard BioTools Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $580 |
| 2024-12-31 | $612 |
| 2024-09-30 | $682 |
| 2024-06-30 | $709 |
| 2024-03-31 | $778 |
| 2023-12-31 | $323 |
| 2023-09-30 | $339 |
| 2023-06-30 | $356 |
| 2023-03-31 | $372 |
| 2022-12-31 | $390 |
| 2022-09-30 | $415 |
| 2022-06-30 | $441 |
| 2022-03-31 | $272 |
| 2021-12-31 | $275 |
| 2021-09-30 | $282 |
| 2021-06-30 | $289 |
| 2021-03-31 | $305 |
| 2020-12-31 | $325 |
| 2020-09-30 | $323 |
| 2020-06-30 | $282 |
| 2020-03-31 | $290 |
| 2019-12-31 | $265 |
| 2019-09-30 | $269 |
| 2019-06-30 | $284 |
| 2019-03-31 | $291 |
| 2018-12-31 | $304 |
| 2018-09-30 | $252 |
| 2018-06-30 | $259 |
| 2018-03-31 | $270 |
| 2017-12-31 | $287 |
| 2017-09-30 | $292 |
| 2017-06-30 | $279 |
| 2017-03-31 | $292 |
| 2016-12-31 | $306 |
| 2016-09-30 | $320 |
| 2016-06-30 | $342 |
| 2016-03-31 | $354 |
| 2015-12-31 | $370 |
| 2015-09-30 | $378 |
| 2015-06-30 | $389 |
| 2015-03-31 | $395 |
| 2014-12-31 | $408 |
| 2014-09-30 | $410 |
| 2014-06-30 | $418 |
| 2014-03-31 | $425 |
| 2013-12-31 | $117 |
| 2013-09-30 | $114 |
| 2013-06-30 | $112 |
| 2013-03-31 | $113 |
| 2012-12-31 | $114 |
| 2012-09-30 | $117 |
| 2012-06-30 | $65 |
| 2012-03-31 | $71 |
| 2011-12-31 | $79 |
| 2011-09-30 | $83 |
| 2011-06-30 | $86 |
| 2011-03-31 | $95 |
| 2010-12-31 | $25 |
| 2010-09-30 | $22 |
| 2010-06-30 | $0 |
| 2010-03-31 | $0 |
| 2009-09-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.350B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.908B | 52.36 |
| Hims & Hers Health (HIMS) | United States | $12.273B | 127.51 |
| Tempus AI (TEM) | United States | $10.830B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.555B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.224B | 66.00 |
| Privia Health (PRVA) | United States | $2.787B | 190.50 |
| Enovis (ENOV) | United States | $1.803B | 10.05 |
| Clover Health Investments (CLOV) | United States | $1.623B | 0.00 |
| Schrodinger (SDGR) | United States | $1.570B | 0.00 |
| Phreesia (PHR) | United States | $1.431B | 0.00 |
| Omnicell (OMCL) | United States | $1.322B | 23.33 |
| Azenta (AZTA) | United States | $1.236B | 57.45 |
| 10x Genomics (TXG) | United States | $1.006B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.537B | 0.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Talkspace (TALK) | United States | $0.472B | 141.00 |
| Claritev (CTEV) | United States | $0.437B | 0.00 |
| TruBridge (TBRG) | United States | $0.357B | 791.00 |
| Outset Medical (OM) | United States | $0.318B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.190B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.140B | 0.00 |
| Pulmonx (LUNG) | United States | $0.125B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.123B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.096B | 0.00 |
| CareCloud (CCLD) | United States | $0.084B | 3.21 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |